GeNeuro SA
EPA:GNRO.PA
0.065 (EUR) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0.007 | 0.015 | 0.006 | 0.003 | 7.306 | 0.021 |
| Cost of Revenue
| 0.294 | 0.289 | 0.3 | 0.335 | 0.355 | 0.071 | 0.072 | 0.043 | 0.032 | 0 | 0 |
| Gross Profit
| -0.294 | -0.289 | -0.3 | -0.335 | -0.355 | -0.063 | -0.057 | -0.037 | -0.029 | 7.306 | 0.021 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | -8.5 | -3.843 | -6.283 | -11.523 | 1 | 1 |
| Reseach & Development Expenses
| 12.305 | 9.675 | 4.722 | 4.537 | 5.977 | 0.013 | 0.018 | 0.015 | 0.006 | 3.643 | 2.651 |
| General & Administrative Expenses
| 2.971 | 0.003 | 0.003 | 0.003 | 0.004 | 0.005 | 0.004 | 0.004 | 0.002 | 1.001 | 0.28 |
| Selling & Marketing Expenses
| -0.071 | 3.075 | 2.491 | 3.128 | 3.557 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 2.9 | 3.079 | 2.494 | 3.131 | 3.561 | 0.005 | 0.005 | 0.004 | 0.002 | 1.001 | 0.28 |
| Other Expenses
| -0.001 | -0.013 | -0.024 | -0.038 | -0.027 | -0.034 | -0.052 | -0.077 | -0.027 | 0 | 0 |
| Operating Expenses
| 15.207 | 12.767 | 7.239 | 7.706 | 9.564 | 0.016 | 0.021 | 0.02 | 0.007 | 5.105 | 3.372 |
| Operating Income
| -15.501 | -13.055 | -7.539 | -8.041 | -9.919 | -0.008 | -0.006 | -0.012 | -0.004 | 2.201 | -3.351 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | -1.084 | -0.384 | -2.068 | -1.702 | 0.301 | -158.825 |
| Total Other Income Expenses Net
| 0.192 | -0.459 | -0.286 | -1.476 | -0.454 | -0 | -0 | -0.002 | -0 | 0.025 | -0.169 |
| Income Before Tax
| -15.309 | -13.514 | -7.825 | -9.516 | -10.373 | -0.008 | -0.006 | -0.014 | -0.004 | 2.226 | -3.52 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | -1.116 | -0.391 | -2.382 | -1.758 | 0.305 | -166.844 |
| Income Tax Expense
| -0.552 | -1.314 | -1.007 | -0.554 | -0.912 | -1.918 | -1.359 | 0 | 0 | 0.45 | -0.022 |
| Net Income
| -14.757 | -12.2 | -6.818 | -8.962 | -9.461 | -0.008 | -0.006 | -0.014 | -0.004 | 1.776 | -3.499 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | -1.116 | -0.391 | -2.383 | -1.767 | 0.243 | -165.82 |
| EPS
| -0.59 | -0.51 | -0.32 | -0.45 | -0.65 | -0.57 | -0.4 | -1.02 | -0.37 | 0.15 | -0.29 |
| EPS Diluted
| -0.59 | -0.51 | -0.32 | -0.45 | -0.65 | -0.57 | -0.4 | -1.02 | -0.37 | 0.15 | -0.29 |
| EBITDA
| -15.207 | -12.767 | -7.239 | -7.706 | -9.564 | -0.008 | -0.006 | -0.012 | -0.004 | 2.27 | -3.342 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | -1.076 | -0.38 | -2.061 | -1.691 | 0.311 | -158.398 |